NORTHCOTT JOHN 4
4 · NEKTAR THERAPEUTICS · Filed Dec 20, 2021
Insider Transaction Report
Form 4
NORTHCOTT JOHN
SVP & Chief Commercial Officer
Transactions
- Award
Stock Option
2021-12-16+67,150→ 67,150 totalExercise: $13.22Exp: 2029-12-15→ Common Stock (67,150 underlying) - Award
Common Stock
2021-12-16+37,800→ 232,654 total
Footnotes (2)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service.
- [F2]This stock option vests over four years from the date of grant in equal monthly installments based on continued service.